Refine
H-BRS Bibliography
- yes (39) (remove)
Departments, institutes and facilities
- Fachbereich Angewandte Naturwissenschaften (39) (remove)
Document Type
- Article (25)
- Conference Object (5)
- Part of a Book (3)
- Report (3)
- Doctoral Thesis (2)
- Book review (1)
Year of publication
- 2016 (39) (remove)
Keywords
- Dielectric analysis (2)
- Lignin (2)
- dielectric analysis (2)
- reaction kinetics (2)
- 31P NMR (1)
- 5-Oxoprolinase (1)
- 5-oxoprolinuria (1)
- Age estimation (1)
- Aminoacylase 1 (1)
- Analytics (1)
- Analytische Chemie (1)
- Aspartic acid racemization (1)
- Aspartoacylase (1)
- Automation (1)
- Beech wood (1)
- Biobased polymeric material (1)
- Biochemische Analyse (1)
- Biomass (1)
- CD30+ cells (1)
- CIK cells (1)
- CIK-Zellen (1)
- Camphorquinone (1)
- Canavan disease (1)
- Cannabinoids (1)
- Chaetocin (1)
- Chemical resource (1)
- Depth Of Cure (1)
- Desinfektion (1)
- Dimethacrylate (1)
- Dystonia (1)
- Elution (1)
- Endosomes (1)
- Engineering (1)
- Failure analysis (1)
- Filler content (1)
- Fourier-transform infrared spectroscopy (1)
- GC/MS (1)
- Gas chromatography/mass spectrometry (GC/MS) (1)
- Glutathione synthetase (1)
- Industrial applications (1)
- Infrarotmikroskopie (1)
- Ion viscosity (1)
- Irradiance Distribution (1)
- Kinetics (1)
- Laser-Beam Profiler (1)
- Light Curing Units (1)
- Liquid-liquid extraction (LLE) (1)
- Lysosomes (1)
- MAPO (1)
- MPV17 monoclonal antibody (1)
- Method validation (1)
- Mitochondria (1)
- Mitochondrial DNA depletion syndrome (1)
- Movement disorder (1)
- N-acylated amino acids (1)
- Organosolv (1)
- Organosolv process (1)
- Peroxisomes (1)
- Photoinitiator (1)
- Photopolymerization (1)
- Poly(acrylonitrile-co-1,3-butadiene-co-styrene)/polyamide 6 (ABS/PA 6) blends (1)
- Pyroglutamic aciduria (1)
- Pyrolysis (1)
- Pyrolysis-GC/FID (1)
- Pyrolysis-GC/MS (1)
- Pyrolysis–GC/MS (1)
- Quantification (1)
- Raman-Spektroskopie (1)
- Resin based composite (1)
- Resin composite (1)
- Rheology (1)
- SGN-35 (1)
- Scanning electron microscopy (SEM) (1)
- Sclera (1)
- Shear viscosity (1)
- Single Lens Reflex Camera (1)
- Trapped radicals (1)
- Unconjugated THC-COOH (1)
- Visible light curing resin (1)
- Wasserverteilung (1)
- X-ray photoelectron spectroscopy (1)
- Zytokin-induzierte Killerzellen (1)
- antibody–drug conjugate (1)
- apoptosis (1)
- autophagy (1)
- biomolecules (1)
- breast cancer (1)
- chaetocin (1)
- clear cell renal cell carcinoma (1)
- conditioned media (1)
- confocal fluorescence microscopy (1)
- curing behavior (1)
- cytokine-induced killer (CIK) cells (1)
- cytokine-induced killer cells (1)
- dielektrická analýza (1)
- distribuce záření (1)
- fotokompozit (1)
- hardness testing (1)
- heat-transfer method (1)
- iPad (1)
- ion viscosity (1)
- kinetika vytvrzování (1)
- klarzelliges Nierenzellkarzinom (1)
- light distribution (1)
- lymphoma (1)
- mesenchymal stem cells (1)
- molecule-surface interactions (1)
- nanocrystalline diamond (1)
- photo-polymerization (1)
- resin for 3D-printing (1)
- self-assembled monolayers (1)
- single-nucleotide polymorphisms in DNA (1)
- structure prediction (1)
- surfaces (1)
- synthetic sapphire (1)
- thermogravimetric analysis (1)
- tvrdost (1)
- viscoelastic properties (1)
- visible light curing resin based composites (1)
- viskoelastické vlastnosti (1)
- vytvrzování světlem (1)
- γ-glutamyl cycle (1)
Bisher ist nicht bekannt, in welchem Ausmaß Fremd- oder Störgerüche dazu geeignet sind, die allgemeine Leistungsfähigkeit eines Sprengstoffspürhundes einzuschränken oder sogar die Detektion eines Sprengkörpers zu verhindern. Ziel ist es zu untersuchen, inwieweit sich durch den gezielten Einsatz von Störsubstanzen die Sprengstoffdetektionsfähigkeit von Spürhunden beeinflussen lässt. Mit Detektionsfähigkeit ist hier sowohl die Wahrscheinlichkeit einer richtigen Detektion von Sprengstoffen in Gegenwart von starken Fremdgerüchen, als auch die ebenfalls zu erwartende Verringerung der Einsatzdauer (vorzeitige Erschöpfung) gemeint.
Brentuximab vedotin (SGN-35) is an antibody–drug conjugate with a high selectivity against CD30+ cell lines and more than 300-fold less activity against antigen-negative cells. In the last years, the results of many in vitro and in vivo studies have led to the fast approval of this drug to treat lymphoma patients. Another innovative method to treat tumor cells including lymphoma cells is the use cytokine-induced killer (CIK) cells, which have also been approved and proven to be a safe treatment with only minor adverse events. In this study, a possible additive effect when combining SGN-35 with CIK cells was investigated. The combinational treatment showed that it reduces the viability of CD30+ cell lines significantly in vitro. Additionally, the amount of lymphoma cells was significantly reduced when exposed to CIK cells as well as when exposed to SGN-35. A significant negative effect of SGN-35 on the function of CIK cells could be excluded. These results lead to the assumption that SGN-35 and CIK cells in combination might achieve better results in an in vitro setting compared to the single use of SGN-35 and CIK cells. Further investigations in in vivo models must be conducted to obtain a better understanding of the exact mechanisms of both treatments when applied in combination.
Bone regeneration and replacement is a major focus in regenerative medicine since degenerative diseases and tumor surgery as well as accidents or dangerous recreational behavior is leading to an increasing need for bone reconstruction strategies. Especially for critical size bone defects, tissue engineering with mesenchymal stem cells is extensively studied because these cells are functioning as precursors for osteoblast in vivo. Nevertheless to reproduce the complex interaction of various factors in vitro is not an easy approach and further investigations have to be done. The status quo is summarized. A variety of growth and transcription factors are known to be involved in osteogenesis with bone morphogenetic proteins (BMPs) and the transcription factor Runx2 being the most extensively studied ones. But also PPAR γ and Osterix are generally regarded as the master regulators of osteoblast differentiation. Recently the large family of purinergic receptors has proven to be essential molecules in osteogenesis as well. In addition, scaffolding is needed to create a three-dimensional tissue. Recent developments in scaffold design are summarized, including natural and synthetic materials with or without the use of bioactive molecules constructed to mimic the natural environment. The status quo of scaffold fabrication methods such as 3D nanoprinting and their influence on cell-scaffold interactions is discussed. In this review we summarize the most interesting results and our related work focusing on two joined approaches: 1) the complex interaction of the most promising factors improving or accelerating osteogenic differentiation and ii) the development of scaffold materials with osteoconductive and osteoinductive properties.
During the last 50 years, a broad range of visible light curing resin based composites (VLC RBC) was developed for restorative applications in dentistry. Correspondingly, the technologies of light curing units (LCU) have changed from UV to visible blue light, and there from quartz tungsten halogen over plasma arc to LED LCUs increasing their light intensity significantly. In this thesis, the influence of the curing conditions in terms of irradiance, exposure time and irradiance distribution of LCU on reaction kinetics as well as corresponding mechanical and viscoelastic properties were investigated.
Large bone defects require fabricated bone constructs that consist of three main components: an artificial extracellular matrix scaffold, stem cells with the potential to differentiate into osteoblasts, and bioactive substances, such as osteoinductive growth factors to direct the growth and differentiation of cells toward osteogenic lineage within the scaffold.
3D-Printing is an efficient method in the field of additive manufacturing. In order to optimize the properties of manufactured parts it is essential to adapt the curing behavior of the resin systems with respect to the requirements. Thus, effects of resin composition, e.g. due to different additives such as thickener and curing agents, on the curing behavior have to be known. As the resin transfers from a liquid to a solid glass the time dependent ion viscosity was measured using DEA with flat IDEX sensors. This allows for a sensitive measurement of resin changes as the ion viscosity changes two to four decades. The investigated resin systems are based on the monomers styrene and HEMA. To account for the effects of copolymerization in the calculation of the reaction kinetics it was assumed that the reaction can be considered as a homo-polymerization having a reaction order n?1. Then the measured ion viscosity curves are fitted with the solution of the reactions kinetics - the time dependent degree of conversion (DC-function) - for times exceeding the initiation phase representing the primary curing. The measured ion viscosity curves can nicely be fitted with the DC-function and the determined fit parameters distinguish distinctly between the investigated resin compositions.
Beta-ketothiolase deficiency, also known as mitochondrial acetoacetyl-CoA thiolase (T2) deficiency, is an autosomal recessive disease caused by mutations in the acetylCoA acetyltransferase 1 (ACAT1) gene. A German T2deficient patient that developed a severe ketoacidotic episode at the age of 11 months, was revealed to be a compound heterozygote of a previously reported null mutation, c.472A>G (p.N158D) and a novel mutation, c.949G>A (p.D317N), in ACAT1. The c.949G>A mutation was suspected to cause aberrant splicing as it is located within an exonic splicing enhancer sequence (c. 947CTGACGC) that is a potential binding site for serine/argininerich splicing factor 1. A mutation in this sequence, c.951C>T, results in exon 10 skipping. A minigene construct was synthesized that included exon 9truncated intron 9exon 10truncated intron 10exon 11, and the splicing of this minigene revealed that the c.949G>A mutant construct caused exon 10 skipping in a proportion of the transcripts. Furthermore, additional substitution of G for C at the first nucleotide of exon 10 (c.941G>C) abolished the effect of the c.949G>A mutation. Transient expression analysis of the c.949G>A mutant cDNA revealed no residual T2 activity in the mutated D317N enzyme. Therefore, c.949G>A (D317N) is a pathogenic missense mutation, and diminishes the effect of an exonic splicing enhancer and causes exon 10 skipping. The present study demonstrates that a missense mutation, or even a synonymous substitution, may disrupt enzyme function by interference with splicing.